Clinical Cardiology Pearls CME Conference
4/7/2021
Author:
UW Medicine Heart Institute
Primary Prevention Pearls and Guideline Review by UW Medicine Faculty
Date & Location
Friday, April 23, 2021, 8:00 AM - 5:00 PM, Online via webinar
Brochure and Registration. Credits
AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician (7.00 hours)Overview
This course is tailored for a primary care audience and is intended to provide practical, up-to-date information on commonly encountered cardiovascular diseases. World-class faculty from the University of Washington School of Medicine will teach participants using case-based lectures and Zoom polling to encourage interactive dialogue. Recent guidelines for hypertension, cholesterol management, and diabetes will be reviewed. Everyday primary care topics including diagnosis and treatment of coronary artery disease, congestive heart failure, valvular heart disease and supraventricular arrhythmias, including atrial fibrillation, will be covered. Practical issues regarding use of new anticoagulants and appropriateness of cardiac testing will be discussed.
Objectives
Upon completion of this activity, attendees should be able to:
- Treat and manage high blood pressure based on updated clinical guidelines from 2020.
- Apply cholesterol guidelines and latest clinical trial data of novel cholesterol treatments to the management of patients with cardiac risk factors and atherosclerotic vascular disease.
- Evaluate patients with chest pain and order the appropriate stress and imaging tests for your patients based on current guidelines.
- Evaluate and manage patients with valvular heart disease; identify which heart murmur patients should be referred for an echocardiogram and when patients should be referred for valve repair or replacement.
- Diagnose and treat patients with palpitations, and understand the appropriate use of heart rhythm monitors and when to refer patients to cardiology.
- Evaluate and treat atrial fibrillation and learn how to use direct oral anticoagulants to reduce stroke risk from atrial fibrillation.
- Evaluate patients with heart failure and treat with guideline directed medical therapy including novel treatments like SGLT2 inhibitors.
- Utilize novel diabetes drugs that have proven benefit in reducing cardiovascular events.
Registration
| |
| All Learners | $200.00 |
| *Resident/Fellow/Student | $125.00 |
*Resident/Fellow/Student rate requires written confirmation of current status. Failure to provide required documentation may result in an additional balance owed.